Thyroid Disorders in Patients Treated with Dimethyl Fumarate for Multiple Sclerosis: A Retrospective Observational Study

por Renaud, Cédric O., Ziros, Panos G., Mathias, Amandine, Pot, Caroline, Sykiotis, Gerasimos P.
Publicado 2022

Keap1/Nrf2 Signaling: A New Player in Thyroid Pathophysiology and Thyroid Cancer

por Renaud, Cedric O., Ziros, Panos G., Chartoumpekis, Dionysios V., Bongiovanni, Massimo, Sykiotis, Gerasimos P.
Publicado 2019

The Keap1/Nrf2 Signaling Pathway in the Thyroid—2020 Update

por Thanas, Christina, Ziros, Panos G., Chartoumpekis, Dionysios V., Renaud, Cédric O., Sykiotis, Gerasimos P.
Publicado 2020

Mice Hypomorphic for Keap1, a Negative Regulator of the Nrf2 Antioxidant Response, Show Age-Dependent Diffuse Goiter with Elevated Thyrotropin Levels

por Ziros, Panos G., Renaud, Cédric O., Chartoumpekis, Dionysios V., Bongiovanni, Massimo, Habeos, Ioannis G., Liao, Xiao-Hui, Refetoff, Samuel, Kopp, Peter A., Brix, Klaudia, Sykiotis, Gerasimos P.
Publicado 2021

Interaction of Genetic Variations in NFE2L2 and SELENOS Modulates the Risk of Hashimoto's Thyroiditis

por Santos, Liliana R., Durães, Cecília, Ziros, Panos G., Pestana, Ana, Esteves, César, Neves, Celestino, Carvalho, Davide, Bongiovanni, Massimo, Renaud, Cédric O., Chartoumpekis, Dionysios V., Habeos, Ioannis G., Simões, Manuel Sobrinho, Soares, Paula, Sykiotis, Gerasimos P.
Publicado 2019